Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3635429014 | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | en | Definition | Active | Entire term case sensitive (core metadata concept) | SNOMED CT core |
1479361015 | Cream | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3534583015 | Cream (basic dose form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
7141000188111 | crème | fr | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Switzerland NRC maintained Module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Is a | Type of drug preparation | false | Inferred relationship | Some | ||
A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Is a | forme pharmaceutique pour usage transdermique et/ou cutané | false | Inferred relationship | Some | ||
A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Is a | A dose form that displays properties between those of a liquid and those of a solid. | true | Inferred relationship | Some | ||
A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Has state of matter (attribute) | A state of matter where particles form a definite shape and support their own weight but have the ability to flow like a liquid when pressure is applied. | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Product containing precisely tolnaftate 10 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
Dithranol 10 mg/g cutaneous cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
Haloprogin 1% cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
Clioquinol + hydrocortisone 3%ww/0.5%ww cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
Ciclopirox olamine 1% cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
Hydrocortisone acetate 10 mg/g and neomycin sulfate 5 mg/g cutaneous cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
Product containing precisely permethrin stain 50 milligram/1 gram conventional release cutaneous cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
Podophyllotoxin 1.5 mg/g cutaneous cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
Dithranol 1 mg/g cutaneous cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
Product containing precisely imiquimod 37.5 milligram/1 milliliter conventional release cutaneous cream (clinical drug) | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
Anthralin 0.4% cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
Fluprednidene acetate 1 mg/g and miconazole nitrate 20 mg/g cutaneous cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
Anthralin 0.2% cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
Iodoquinol+hydrocortisone 1%/1% cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
Butoconazole nitrate 2% cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
Benzoyl peroxide 100 mg/g and potassium hydroxyquinoline sulfate 5 mg/g cutaneous cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
Product containing precisely undecylenic acid 50 milligram/1 gram and zinc undecylenate 200 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
Product containing precisely chlorhexidine hydrochloride 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
Ciclopirox 0.77% cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
Silver sulfadiazine 10mg/g cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
Coal tar 10 mg/mL cutaneous cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
Pimecrolimus 10mg/g cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
Anthralin cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
Nystatin + triamcinolone acetonide 100000unt/1mg cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
Amorolfine (as amorolfine hydrochloride) 2.5 mg/g cutaneous cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
Sertaconazole 2% cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and clioquinol 30 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
Clioquinol+hydrocortisone 3%/0.5% cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
Hydroquinone 40mg cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
Hydroquinone 40mg/gram cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
Electrode cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
Product containing precisely hydroquinone 40 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
Penciclovir 10 mg/g cutaneous cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
Nasal cream | Has basic dose form (attribute) | True | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
Rectal cream | Has basic dose form (attribute) | True | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
Vaginal cream | Has basic dose form (attribute) | True | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
Cutaneous cream | Has basic dose form (attribute) | True | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
crème buccale à libération conventionnelle | Has basic dose form (attribute) | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
Eye cream | Has basic dose form (attribute) | True | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
Ear cream | Has basic dose form (attribute) | True | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
Conventional release transdermal cream (dose form) | Has basic dose form (attribute) | True | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
Conventional release oromucosal cream (dose form) | Has basic dose form (attribute) | True | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some |
Start Page 2 of 2
Reference Sets
Description inactivation indicator reference set